Category: Latest News
-
Brain Implant Helps ‘Locked In’ ALS Patient Communicate
ALS results in loss of ability to communicate.
-
Brain Implant Helps ‘Locked In’ ALS Patient Communicate
ALS results in loss of ability to communicate.
-
The Novartis house that Vasella built gets extreme makeover
By John Miller ZURICH (Reuters) – Signals from Swiss drugmaker Novartis that it could unload its struggling Alcon eyecare business is the latest step in dismantling former leader Dan Vasella's vision of building a European healthcare giant. Chairman Joerg Reinhardt said at the weekend that Alcon's woes have intensified soul-searching over the unit's future. “All…
-
The Novartis house that Vasella built gets extreme makeover
By John Miller ZURICH (Reuters) – Signals from Swiss drugmaker Novartis that it could unload its struggling Alcon eyecare business is the latest step in dismantling former leader Dan Vasella's vision of building a European healthcare giant. Chairman Joerg Reinhardt said at the weekend that Alcon's woes have intensified soul-searching over the unit's future. “All…
-
Iraqi civilians stranded north of Mosul grow desperate
By Stephen Kalin BAYBUKH, Iraq (Reuters) – Hundreds of civilians who fled fighting near Islamic State-controlled Mosul last week are stranded without basic humanitarian assistance, underlining the challenges of the largest military operation in Iraq in over a decade. Families have been living for up to six days in abandoned homes and a school building…
-
Iraqi civilians stranded north of Mosul grow desperate
By Stephen Kalin BAYBUKH, Iraq (Reuters) – Hundreds of civilians who fled fighting near Islamic State-controlled Mosul last week are stranded without basic humanitarian assistance, underlining the challenges of the largest military operation in Iraq in over a decade. Families have been living for up to six days in abandoned homes and a school building…
-
Dynavax says FDA rejects its hepatitis B vaccine
(Reuters) – The U.S. Food and Drug Administration rejected Dynavax Technologies Corp's marketing application for its hepatitis B vaccine, Heplisav-B, for the second time in three years, sending the company's shares tumbling 71 percent in premarket trade. The drug developer said on Monday it received a “complete response letter” from the FDA, seeking information about…
-
Dynavax says FDA rejects its hepatitis B vaccine
(Reuters) – The U.S. Food and Drug Administration rejected Dynavax Technologies Corp's marketing application for its hepatitis B vaccine, Heplisav-B, for the second time in three years, sending the company's shares tumbling 71 percent in premarket trade. The drug developer said on Monday it received a “complete response letter” from the FDA, seeking information about…
-
U.S. regulator has opened Audi investigation: Bild am Sonntag
A U.S. government regulator has started investigating Volkswagen's Audi brand over a reported discovery of a new cheat software device at the luxury carmaker, Bild am Sonntag reported, without citing the source of the information. The German weekly paper said a week ago that the California Air Resources Board (CARB) had this summer discovered cheating…
-
J&J arthritis drug goes up against Humira, with mixed results
(Reuters) – Johnson & Johnson said its experimental sirukumab treatment for rheumatoid arthritis showed mixed results against AbbVie Inc's top-selling Humira in a large trial. By one measure, patients with moderate to severe disease who took sirukumab showed significantly greater improvement in the Phase III study than those taking Humira, J&J said on Saturday. In…